Impact of computerised physician order entry (CPOE) on the incidence of chemotherapy-related medication errors: a systematic review

Eur J Clin Pharmacol. 2021 Aug;77(8):1123-1131. doi: 10.1007/s00228-021-03099-9. Epub 2021 Feb 23.

Abstract

Purpose: Computerised prescriber (or physician) order entry (CPOE) implementation is one of the strategies to reduce medication errors. The extent to which CPOE influences the incidence of chemotherapy-related medication errors (CMEs) was not previously collated and systematically reviewed. Hence, this study was designed to collect, collate, and systematically review studies to evaluate the effect of CPOE on the incidence of CMEs.

Methods: A search was performed of four databases from 1 January 1995 until 1 August 2019. English-language studies evaluating the effect of CPOE on CMEs were selected as per inclusion and exclusion criteria. The total CMEs normalised to total prescriptions pre- and post-CPOE were extracted and collated to perform a meta-analysis using the 'meta' package in R. The systematic review was registered with PROSPERO CRD42018104220.

Results: The database search identified 1621 studies. After screening, 19 studies were selected for full-text review, of which 11 studies fulfilled the selection criteria. The meta-analysis of eight studies with a random effects model showed a risk ratio of 0.19 (95% confidence interval: 0.08-0.44) favouring CPOE (I2 = 99%).

Conclusion: The studies have shown consistent reduction in CMEs after CPOE implementation, except one study that showed an increase in CMEs. The random effects model in the meta-analysis of eight studies showed that CPOE implementation reduced CMEs by 81%.

Keywords: CPOE; Chemotherapy; Medication errors; Patient safety; Prescription.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Consumer Behavior
  • Humans
  • Medical Order Entry Systems / statistics & numerical data*
  • Medication Errors / prevention & control*
  • Patient Acuity

Substances

  • Antineoplastic Agents